Back to Search
ROBERT MARTELL, MD
MD
Medical Oncology Physician
NPI: 1477788099IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
039142(CT)042.0017216(VT)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE
Class of 1993
Research & Publications (20)
Source-monitoring training: toward reducing rater expectancy effects in behavioral measurement.
PMID 16162067·J Appl Psychol·2005
8-other
Reducing the performance-cue bias in work behavior ratings: can groups help?
PMID 12558211·J Appl Psychol·2002
8-other
Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
PMID 12111110·Cancer Chemother Pharmacol·2002
3-trial
A diagnostic-ratio approach to measuring beliefs about the leadership abilities of male and female managers.
PMID 11768063·J Appl Psychol·2001
8-other
Histone deacetylase inhibitors in cancer therapy: new compounds and clinical update of benzamide-type agents.
PMID 18673170·Curr Top Med Chem·2008
6-review
Evaluation of the pharmacodynamic effects of MGCD0103 from preclinical models to human using a novel HDAC enzyme assay.
PMID 18519775·Clin Cancer Res·2008
3-trial
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia.
PMID 18495956·Blood·2008
3-trial
Phase I study of MGCD0103 given as a three-times-per-week oral dose in patients with advanced solid tumors.
PMID 18421048·J Clin Oncol·2008
3-trial
A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors.
PMID 17938863·Invest New Drugs·2008
3-trial
Phase I trial of weekly paclitaxel and BMS-214662 in patients with advanced solid tumors.
PMID 17510207·Clin Cancer Res·2007
3-trial
Retaining pathological gamblers in cognitive behavior therapy through motivational enhancement: A pilot study.
PMID 16574817·Behav Modif·2006
8-other
A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer.
PMID 15756013·Clin Cancer Res·2005
3-trial
The NCI/CIT microArray database (mAdb) system - bioinformatics for the management and analysis of Affymetrix and spotted gene expression microarrays.
PMID 14728569·AMIA Annu Symp Proc·2003
7-preclinical
Antiretroviral therapy in a community clinic--early lessons from a pilot project.
PMID 12916388·S Afr Med J·2003
8-other
Optimizing aptamer activity for gene therapy applications using expression cassette SELEX.
PMID 12095300·Mol Ther·2002
8-other
Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology.
PMID 11821460·J Clin Oncol·2002
8-other
Reconstitution of dna synthetic capacity in senescent normal human fibroblasts by expressing cellular factors E2F and Mdm2.
PMID 11640890·Exp Cell Res·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 800 WASHINGTON ST
BOSTON, MA 02111 - Phone
- (617) 636-8884
Quick Facts
- NPI
- 1477788099
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile